Ticker brief
NTLA INTELLIA THERAPEUTICS INC
Consumer, Non-cyclical · Biotechnology
last close
$12.87
1 day
-1.8%
14 days
+8.1%
mkt cap
$2.5B
signals 14d
10
authors 14d
8
crowd 14d
-0.2σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 114% rich · 92 pctile own 1y | IV/HV 1.94× (as of 2026-08-27) |
| Skew — 25Δ RR 30d | +0.065 51 pctile own 1y | balanced vs own range |
| Net dealer OI (NDOI) | +3.10 elevated | 5-session Δ +0.71 (as of 2026-07-06) |
| OI alarm | quiet | last alarm 2026-04-28 (z=2.9) |
| Next earnings | 2026-11-05 (proj) | in 69d |
Sentiment — last 14 days
daily mean sentiment, 2026-08-15 → 2026-08-28 · now +0.60 (−1 bearish … +1 bullish)
Who spoke8
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @SixSigmaCapital | B | -0.40 | 3 | -0.20 |
| @AlphaScout360 | C | -4.45 | 1 | +0.80 |
| @alphacharts | B | -3.11 | 1 | +0.00 |
| @beach_trades | C | -0.04 | 1 | +0.25 |
| @hiddensmallcaps | B | -0.77 | 1 | +0.40 |
| @PSInvestor | B | -1.48 | 1 | +0.30 |
| @Sir_Kory | C | -0.11 | 1 | +0.50 |
| @OwenGregorian | C | -1.78 | 1 | +0.60 |
Recent signals10of 10 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-28 | @OwenGregorian | +0.60 | Intellia's Phase 3 therapy cut attacks 87% versus placebo and entered a rolling FDA submission. | — | tweet ↗ |
| 2026-08-25 | @Sir_Kory | +0.50 | Frames gene editing as a large long-term market and compares four public platforms by maturity and risk. | -4.7% | tweet ↗ |
| 2026-08-23 | @SixSigmaCapital | -0.70 | Reviews a past healthcare basket, including TWST gains and a realized 50% NTLA loss. | +0.2% | tweet ↗ |
| 2026-08-21 | @PSInvestor | +0.30 | Reports ARK Invest's dated buy list; output is capped at the six directly listed purchases. | +0.2% | tweet ↗ |
| 2026-08-21 | @hiddensmallcaps | +0.40 | Compares gene-editing basket valuations with IONQ to argue biotech sentiment has room to improve. | +0.2% | tweet ↗ |
| 2026-08-21 | @beach_trades | +0.25 | Directs NTLA observers to CRSP's move, implying a favorable peer read-through. | +0.2% | tweet ↗ |
| 2026-08-19 | @SixSigmaCapital | -0.30 | Calls VKTX a good idea while noting a negative past experience with NTLA. | -3.1% | tweet ↗ |
| 2026-08-19 | @SixSigmaCapital | +0.40 | Offers NTLA and PRME as highly speculative bullish candidates. | -3.1% | tweet ↗ |
| 2026-08-19 | @alphacharts | +0.00 | Identifies a giant inverse head-and-shoulders base in CRSP. | -3.1% | tweet ↗ |
| 2026-08-15 | @AlphaScout360 | +0.80 | Bullish NTLA entry now, targeting a test of $28. — Identifies the current price as an asymmetric bullish entry with a $28 target. | +8.1% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.